Carmen Chang's Net Worth
$57.6 Million
Who is Carmen Chang?
Carmen Chang has an estimated net worth of $57.6 Million. This is based on reported shares across multiple companies, which include Bright Health Group Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Coursera, Inc., GENOCEA BIOSCIENCES, INC., Metacrine, Inc., Savara Inc, Trevi Therapeutics, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Arsanis, Inc., Regulus Therapeutics Inc., Marker Therapeutics, Inc., and Korro Bio, Inc..
SEC CIK
Carmen Chang's CIK is 0001746342
Past Insider Trading and Trends
2021 was Carmen Chang's most active year for acquiring shares with 16 total transactions. Carmen Chang's most active month to acquire stocks was the month of May. 2021 was Carmen Chang's most active year for disposing of shares, totalling 11 transactions. Carmen Chang's most active month to dispose stocks was the month of May. 2022 saw Carmen Chang paying a total of $350,199,999.40 for 6,926,881 shares, this is the most they've acquired in one year. In 2022 Carmen Chang cashed out on 14,671,143 shares for a total of $750,662.12, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NeueHealth, Inc. (BHG) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
∞
| 71.91M |
$18.00 |
—
| 71.91M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Monte Rosa Therapeutics, Inc. (GLUE) Snapshot price: $4.68
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 7.69M |
$19.00 |
—
| 7.69M |
Jun 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Mirum Pharmaceuticals, Inc. (MIRM) Snapshot price: $26.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -47.77% | -2.00M |
—
|
—
| 2.19M |
Jun 13
| |||
Form 4
|
∞
| 4.19M |
$15.00 |
—
| 4.19M |
Jul 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Coursera, Inc. (COUR) Snapshot price: $17.44
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +51.16% | 16.19K |
—
|
—
| 47.83K |
May 24
| |||
Form 4
| -3.73% | -1.23K |
$11.82 | -$14,496.59 | 31.64K |
Mar 15
| |||
Form 4
| +3.87% | 1.23K |
—
|
—
| 32.87K |
Feb 15
| |||
Form 4
| +37.65% | 8.65K |
—
|
—
| 31.64K |
May 13
| |||
Form 4
|
∞
| 22.98K |
—
|
—
| 22.98K |
Nov 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GENOCEA BIOSCIENCES, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -10.38M |
$0.07 | -$750,662.12 |
0
|
May 24 - May 25
| |||
Form 4
| +43.61% | 3.15M |
$2.25 | $7,090,335.00 | 10.38M |
Jul 24
| |||
Form 4
| +65.40% | 2.86M |
$3.50 | $9,999,997.00 | 7.23M |
Jun 24
| |||
Form 4
| +39.79% | 9.95M |
$0.47 | $4,688,619.18 | 34.95M |
Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |